Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.
Adult
Asymptomatic Infections
Betacoronavirus
/ isolation & purification
COVID-19
COVID-19 Testing
California
/ epidemiology
Clinical Laboratory Techniques
/ methods
Coronavirus Infections
/ diagnosis
Delivery, Obstetric
/ methods
Female
Hospitalization
/ statistics & numerical data
Humans
Pandemics
Pneumonia, Viral
/ diagnosis
Pregnancy
Pregnancy Complications, Infectious
/ diagnosis
Pregnancy Outcome
Prevalence
SARS-CoV-2
Journal
American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
4
7
2020
medline:
17
9
2020
entrez:
4
7
2020
Statut:
ppublish
Résumé
The coronavirus disease 2019 (COVID-19) pandemic has created a need for data regarding the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnant women. After implementing universal screening for COVID-19 in women admitted for delivery, we sought to describe the characteristics of COVID-19 in this large cohort of women. An observational study of women admitted to labor and delivery units in Kaiser Permanente Southern California (KPSC) hospitals between April 6 and May 11, 2020 who were universally offered testing for SARS-CoV-2 infection ( Of women delivered during the study period, 3,923 (99.0%) underwent SARS-CoV-2 testing. A total of 17 (0.43%; 95% confidence interval: 0.23-0.63%) women tested positive, and none of them were symptomatic on admission. There was no difference in terms of characteristics between SARS-CoV-2 positive and negative tested women. One woman developed a headache attributed to COVID-19 3 days postpartum. No neonates had a positive test at 24 hours of life. The findings suggest that in pregnant women admitted for delivery between April 6 and May 11, 2020 in this large integrated health care system in Southern California, prevalence of SARS-CoV-2 test positive was very low and all patients were asymptomatic on admission. · The prevalence of SARS-CoV-2 infection in a large diverse cohort of term pregnant women was 0.43%.. · 99% of women accepted SARS-CoV-2 screening on admission to labor and delivery.. · All women with positive test results were asymptomatic at the time of testing..
Identifiants
pubmed: 32620022
doi: 10.1055/s-0040-1714060
pmc: PMC7516390
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1110-1114Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
None declared.
Références
Am J Obstet Gynecol MFM. 2020 May;2(2):100118
pubmed: 32292903
Am J Obstet Gynecol. 2020 Aug;223(2):284-286
pubmed: 32348743
Clin Infect Dis. 2020 Jul 28;71(15):844-846
pubmed: 32119083
Am J Perinatol. 2020 Jun;37(8):861-865
pubmed: 32305046
JAMA Pediatr. 2020 Jul 1;174(7):722-725
pubmed: 32215598
Transl Pediatr. 2020 Feb;9(1):51-60
pubmed: 32154135
N Engl J Med. 2020 May 28;382(22):2163-2164
pubmed: 32283004
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
JAMA. 2020 May 12;323(18):1846-1848
pubmed: 32215581